Condition: House Dust Mite Allergy · Sponsor: Probelte Pharma S.L.U.
The trial is performed to assess efficacy and safety of Beltavac with polymerized extract of house dust mites in allergic Rhinoconjunctivitis associated or not with asthma
This description comes directly from the study's public registry record.
Inma Buendia · +34 608 933 618 · inmaculadabuendia@probeltepharma.es
Always discuss trial participation with your own doctor first.
| Hospital Vega Baja | Orihuela, Alicante, Spain | Recruiting |
| Hospital General de Granollers | Granollers, Barcelona, Spain | Recruiting |
| Hospital de Canarias | Santa Cruz de Tenerife, Canary Islands, Spain | Withdrawn |
| Hospital de la Plana | Castellon, Castellón, Spain | Recruiting |
| Hospital Regional de Málaga | Málaga, Málaga, Spain | Recruiting |
| Complejo Hospitalario de Navarra | Pamplona, Navarre, Spain | Recruiting |
| Fundacion Sanitaria Sant Pere Claver | Barcelona, Spain | Recruiting |
| Hospital de Bellvitge | Barcelona, Spain | Recruiting |
| Hospital Germans Trias i Pujol | Barcelona, Spain | Recruiting |
| Hospital infantil Vall d Hebron | Barcelona, Spain | Recruiting |
| Hospital Val d ' Hebron | Barcelona, Spain | Recruiting |
| Hospital General de Castellón | Castelló, Spain | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05395689